KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 74 filers reported holding KALA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $130,000 | +828.6% | 14,718 | +302.0% | 0.00% | – |
Q3 2019 | $14,000 | -97.8% | 3,661 | -92.1% | 0.00% | -100.0% |
Q2 2018 | $634,000 | -17.3% | 46,160 | -4.8% | 0.00% | -50.0% |
Q1 2018 | $767,000 | -92.7% | 48,480 | -91.5% | 0.00% | -90.9% |
Q4 2017 | $10,514,000 | -15.3% | 568,635 | +4.6% | 0.02% | -21.4% |
Q3 2017 | $12,414,000 | – | 543,525 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 1,333,333 | $5,073,000 | 100.00% |
CAXTON CORP | 1,483,343 | $5,644,000 | 6.36% |
Polaris Venture Management Co. V, L.L.C. | 1,197,032 | $4,555,000 | 2.59% |
RA Capital Management | 4,537,478 | $17,265,000 | 1.03% |
Orbimed Advisors | 3,447,840 | $13,119,000 | 0.25% |
Matisse Capital | 46,500 | $177,000 | 0.22% |
PURA VIDA INVESTMENTS, LLC | 332,831 | $1,266,000 | 0.22% |
Sofinnova Investments, Inc. | 478,206 | $1,819,000 | 0.16% |
HARBOURVEST PARTNERS LLC | 99,186 | $377,000 | 0.16% |
ALGERT GLOBAL LLC | 47,195 | $180,000 | 0.07% |